Alnylam Pharmaceuticals (ALNY) PT Raised to $135 at Bernstein
Tweet Send to a Friend
Bernstein raised its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $135.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE